Ad
related to: total hip replacement devices recall pdf
Search results
Results from the WOW.Com Content Network
The 2010 DePuy Hip Replacement Recall was instituted when DePuy Orthopaedics, Inc., a division of Johnson and Johnson, recalled its ASR XL Acetabular metal-on-metal hip replacement system on August 24, 2010.
On August 24, 2010, DePuy recalled all ASR hip implant systems sold since 2003. The 2010 DePuy Hip Recall was issued after research released by the National Joint Registry (NJR) found high rates of hip replacement failure for the ASR XL Acetabular and ASR Hip Resurfacing systems.
Hip replacement is a surgical procedure in which the hip joint is replaced by a prosthetic implant, that is, a hip prosthesis. Hip replacement surgery can be performed as a total replacement or a hemi/semi(half) replacement.
The hip resurfacing devices are metal-on-metal articulating devices which differ from total hip replacement devices because they are more bone conserving and retain the natural geometry (so-called large ball THR devices share this trait).
On 2012, FDA has issued a warning for the Stryker Rejuvenate hip replacement after it was discovered that the hip replacement was considered defective and can cause similar side effects to DePuy hip implants. As a result, in 2014, Stryker was fined 1 billion and 2.5 billion respectively for their defective Rejuvenate and ABG II hip replacements ...
On August 24, 2010, DePuy, a subsidiary of American giant Johnson & Johnson, recalled its ASR (articular surface replacement) hip prostheses from the market. DePuy said the recall was due to unpublished National Joint Registry data showing a 12% revision rate for resurfacing at five years and an ASR XL revision rate of 13%.
Jonathan Jeffers is a mechanical engineer and Professor of Mechanical Engineering at Imperial College London. [1] He was awarded a Research Professorship by the National Institute for Health and Care Research (NIHR), [2] [3] the first engineer to receive this award. [4] His research focuses on improving surgical treatment of osteoarthritis.
The devices were recalled because of concerns that foam used in them could degrade and become toxic, carrying potential cancer risks. CEO Roy Jakobs declined to say whether the bill was smaller ...
A hip fracture is a break that occurs in the upper part of the femur (thigh bone), at the femoral neck or (rarely) the femoral head. Symptoms may include pain around the hip, particularly with movement, and shortening of the leg. Usually the person cannot walk. A hip fracture is usually a femoral neck fracture.
Minimally invasive hip resurfacing (MIS) is a total or partial hip surgery that can be carried out through an incision of less than 10 cm (4 inches) without imparting great forces on the anatomy or compromising component positioning.